title: The anti-oxidant properties of 5-aminosalicylic acid.
abstract: Oxidative damage to biological membranes is an important cause of tissue injury in inflammatory bowel disease. 5-Aminosalicylic Acid (5ASA) has therapeutic efficacy in Ulcerative colitis, which may be based on its antioxidant properties. We used Parinaric acid as a fluorescent marker of oxidation in an intestinal microvillous brush border membrane preparation. Various concentrations of the antioxidants 5ASA, ascorbate, and tocopherol were added, and oxidation was initiated from within the membrane by 2,2' azobis (2.4-dimethylvaleronitrile) (AMVN) and from solution by 2,2' azobis (2-amidinopropane) hydrochloride (AAPH). Tocopherol was able to inhibit oxidation from either source. Ascorbate was only able to inhibit oxidation initiated from solution. 5ASA was able to inhibit oxidation initiated from either site, and was more effective than tocopherol against AAPH, but similarly effective against AMVN. We postulate that water soluble 5ASA preferentially associates with membrane surface, allowing chain-breaking antioxidant activity when peroxidation is initiated within the membrane. Likewise, it is effective against aqueous oxidants because its position allows it to interact with AAPH before lipid peroxidation can be initiated as well as breaking the lipid peroxidation chain once it is initiated. This dual capacity may be important for therapeutic effect of 5ASA and may suggest other candidate antioxidants for clinical trials.
authors.affiliation: University of Calgary, Department of Medicine, Alberta, Canada.
authors.forename: D C
authors.initials: DC
authors.lastname: Pearson
authors.forename: D
authors.initials: D
authors.lastname: Jourd'heuil
authors.forename: J B
authors.initials: JB
authors.lastname: Meddings
mesh_terms: D000578:Amidines / Q000494:pharmacology; D000636:Aminosalicylic Acids / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology; D001391:Azo Compounds / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated; D005456:Fluorescent Dyes; D006168:Guinea Pigs; D007422:Intestines / Q000648:ultrastructure; D008297:Male; D019804:Mesalamine; D008871:Microvilli / Q000187:drug effects / Q000378:metabolism; D009570:Nitriles / Q000494:pharmacology; D010084:Oxidation-Reduction; D013050:Spectrometry, Fluorescence; D014810:Vitamin E / Q000494:pharmacology
chemical_list: D000578:Amidines; D000636:Aminosalicylic Acids; D000975:Antioxidants; D001391:Azo Compounds; D005231:Fatty Acids, Unsaturated; D005456:Fluorescent Dyes; D009570:Nitriles; C055792:2,2'-azobis(2,4-dimethylvaleronitrile); D014810:Vitamin E; D019804:Mesalamine; C046728:2,2'-azobis(2-amidinopropane); C013641:parinaric acid; D001205:Ascorbic Acid